<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37585411</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>8</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Membrane metalloendopeptidase (MME) is positively correlated with systemic lupus erythematosus and may inhibit the occurrence of breast cancer.</ArticleTitle><Pagination><StartPage>e0289960</StartPage><MedlinePgn>e0289960</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0289960</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0289960</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with systemic lupus erythematosus (SLE) have a lower risk of breast cancer (BRCA) than the general population. In this study, we explored the underlying molecular mechanism that is dysregulated in both diseases.</AbstractText><AbstractText Label="METHODS">Weighted gene coexpression network analysis (WGCNA) was executed with the SLE and BRCA datasets from the Gene Expression Omnibus (GEO) website and identified the potential role of membrane metalloendopeptidase (MME) in both diseases. Then, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of related proteins and miRNAs were performed to investigate the potential molecular pathways.</AbstractText><AbstractText Label="RESULTS">WGCNA revealed that MME was positively related to SLE but negatively related to BRCA. In BRCA, MME expression was significantly decreased in tumor tissues, especially in luminal B and infiltrating ductal carcinoma subtypes. Receiver operating characteristic (ROC) analysis identified MME as a valuable diagnostic biomarker of BRCA, with an area under the curve (AUC) value equal to 0.984 (95% confidence interval = 0.976-0.992). KEGG enrichment analysis suggested that MME-related proteins and targeted miRNAs may reduce the incidence of BRCA in SLE patients via the PI3K/AKT/FOXO signaling pathway. Low MME expression was associated with favorable relapse-free survival (RFS) but no other clinical outcomes and may contribute to resistance to chemotherapy in BRCA, with an AUC equal to 0.527 (P value &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS">In summary, MME expression was significantly decreased in BRCA but positively correlated with SLE, and it might reduce the incidence of BRCA in SLE patients via the PI3K/AKT/FOXO signaling pathway.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Ding et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Jiatong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chenxi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Kexin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wanying</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brest Surgery, The second affiliated hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Chenxi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brest Surgery, The second affiliated hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenxiong</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-2962-0847</Identifier><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.11</RegistryNumber><NameOfSubstance UI="D015260">Neprilysin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015260" MajorTopicYN="Y">Neprilysin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37585411</ArticleId><ArticleId IdType="pmc">PMC10431625</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0289960</ArticleId><ArticleId IdType="pii">PONE-D-22-34693</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7&#x2013;33. doi: 10.3322/caac.21708</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21708</ArticleId><ArticleId IdType="pubmed">35020204</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke AE, Pooley N, Marjenberg Z, Langham J, Nicholson L, Langham S, et al.. Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis. Semin Arthritis Rheum. 2021; 51(6):1230&#x2013;1241. doi: 10.1016/j.semarthrit.2021.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2021.09.009</ArticleId><ArticleId IdType="pubmed">34710720</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey D, Kenu E, Isenberg DA. Cancer complicating systemic lupus erythematosus-a dichotomy emerging from a nested case-control study. Lupus. 2013; 22(9):919&#x2013;927. doi: 10.1177/0961203313497118</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313497118</ArticleId><ArticleId IdType="pmc">PMC4107831</ArticleId><ArticleId IdType="pubmed">23857987</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update omicronn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021; 80(1):14&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">33051219</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AA, Igusa T, Goldman D, Li J, Casciola-Rosen L, Rosen A, et al.. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection. Arthritis Res Ther. 2021;23(1):64. doi: 10.1186/s13075-021-02449-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02449-3</ArticleId><ArticleId IdType="pmc">PMC7905617</ArticleId><ArticleId IdType="pubmed">33632283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladouceur A, Bernatsky S, Ramsey-Goldman R, Clarke AE. Managing cancer risk in patients with systemic lupus erythematous. Expert Rev Clin Immunol. 2018; 14(10):793&#x2013;802. doi: 10.1080/1744666X.2018.1519394</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2018.1519394</ArticleId><ArticleId IdType="pubmed">30183456</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizerska-Kowalska M, Bojarska-Junak A, Jakubowicz-Gil J, Kandefer-Szerszen M. Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development. Tumour Biol. 2016; 37(10):13355&#x2013;13368. doi: 10.1007/s13277-016-5248-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-016-5248-y</ArticleId><ArticleId IdType="pmc">PMC5097095</ArticleId><ArticleId IdType="pubmed">27460083</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Wang L, Zhan Y, Zeng T, Zhang X, Guan XY, et al.. Membrane Metalloendopeptidase (MME) Suppresses Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) by Inhibiting FAK-RhoA Signaling Axis. Am J Pathol. 2019; 189(7):1462&#x2013;1472. doi: 10.1016/j.ajpath.2019.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2019.04.007</ArticleId><ArticleId IdType="pubmed">31054987</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng CY, Zhou Z, Stone M, Lu B, Flesken-Nikitin A, Nanus DM, et al.. Membrane metalloendopeptidase suppresses prostate carcinogenesis by attenuating effects of gastrin-releasing peptide on stem/progenitor cells. Oncogenesis. 2020; 9(3):38. doi: 10.1038/s41389-020-0222-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41389-020-0222-3</ArticleId><ArticleId IdType="pmc">PMC7090072</ArticleId><ArticleId IdType="pubmed">32205838</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao M, Zhang C, Gao C, Wang Q, Dai M, Yue R, et al.. Exploration of the Shared Gene Signatures and Molecular Mechanisms Between Systemic Lupus Erythematosus and Pulmonary Arterial Hypertension: Evidence From Transcriptome Data. Front Immunol. 2021; 12:658341. doi: 10.3389/fimmu.2021.658341</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.658341</ArticleId><ArticleId IdType="pmc">PMC8320323</ArticleId><ArticleId IdType="pubmed">34335565</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016; 32(18):2847&#x2013;2849. doi: 10.1093/bioinformatics/btw313</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Liu YX, Huang L. ImageGP: An easy-to-use data visualization web server for scientific researchers. iMeta. 2022;1:e5.</Citation></Reference><Reference><Citation>Chen F, Chandrashekar DS, Varambally S, Creighton CJ. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat Commun. 2019; 10(1):5679. doi: 10.1038/s41467-019-13528-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13528-0</ArticleId><ArticleId IdType="pmc">PMC6908580</ArticleId><ArticleId IdType="pubmed">31831737</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo S, Zhong S, Zhang A. Privacy-preserving Kruskal-Wallis test. Comput Methods Programs Biomed. 2013; 112(1):135&#x2013;145. doi: 10.1016/j.cmpb.2013.05.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2013.05.023</ArticleId><ArticleId IdType="pubmed">23871682</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch A, Jeschke J, Van Criekinge W, van Engeland M, De Meyer T. MEXPRESS update 2019. Nucleic Acids Res. 2019; 47(W1):W561&#x2013;W565. doi: 10.1093/nar/gkz445</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz445</ArticleId><ArticleId IdType="pmc">PMC6602516</ArticleId><ArticleId IdType="pubmed">31114869</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Cho JW, Lee S, Yun A, Kim H, Bae D, et al.. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018. Jan 4;46(D1):D380&#x2013;D386. doi: 10.1093/nar/gkx1013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1013</ArticleId><ArticleId IdType="pmc">PMC5753191</ArticleId><ArticleId IdType="pubmed">29087512</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al.. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015; 43(Database issue):D447&#x2013;452. doi: 10.1093/nar/gku1003</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1003</ArticleId><ArticleId IdType="pmc">PMC4383874</ArticleId><ArticleId IdType="pubmed">25352553</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu D, Luo H, Huo P, Wang Z, Zhang S, He Z, et al.. KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis. Nucleic Acids Res. 2021; 49(W1):W317&#x2013;W325. doi: 10.1093/nar/gkab447</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab447</ArticleId><ArticleId IdType="pmc">PMC8265193</ArticleId><ArticleId IdType="pubmed">34086934</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Zhou G, Soufan O, Xia J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020; 48(W1):W244&#x2013;W251. doi: 10.1093/nar/gkaa467</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa467</ArticleId><ArticleId IdType="pmc">PMC7319552</ArticleId><ArticleId IdType="pubmed">32484539</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, et al.. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015; 43(W1):W460&#x2013;466. doi: 10.1093/nar/gkv403</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv403</ArticleId><ArticleId IdType="pmc">PMC4489228</ArticleId><ArticleId IdType="pubmed">25977294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanczky A, Gyorffy B. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. J Med Internet Res. 2021; 23(7):e27633. doi: 10.2196/27633</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/27633</ArticleId><ArticleId IdType="pmc">PMC8367126</ArticleId><ArticleId IdType="pubmed">34309564</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekete JT, Gy&#x151;rffy B. ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J Cancer. 2019; 145(11):3140&#x2013;3151. doi: 10.1002/ijc.32369</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.32369</ArticleId><ArticleId IdType="pubmed">31020993</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees MG, Seashore-Ludlow B, Cheah JH, Adams DJ, Price EV, Gill S, et al.. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016; 12(2):109&#x2013;116. doi: 10.1038/nchembio.1986</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1986</ArticleId><ArticleId IdType="pmc">PMC4718762</ArticleId><ArticleId IdType="pubmed">26656090</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013; 14:7. doi: 10.1186/1471-2105-14-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-7</ArticleId><ArticleId IdType="pmc">PMC3618321</ArticleId><ArticleId IdType="pubmed">23323831</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al.. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498&#x2013;2504. doi: 10.1101/gr.1239303</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, et al.. Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer. 2020; 19(1):22. doi: 10.1186/s12943-020-1147-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-020-1147-3</ArticleId><ArticleId IdType="pmc">PMC6998289</ArticleId><ArticleId IdType="pubmed">32019587</ArticleId></ArticleIdList></Reference><Reference><Citation>Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020; 20(8):417&#x2013;436. doi: 10.1038/s41568-020-0266-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-020-0266-x</ArticleId><ArticleId IdType="pubmed">32528185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022; 95(1130):20211033. doi: 10.1259/bjr.20211033</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr.20211033</ArticleId><ArticleId IdType="pmc">PMC8822551</ArticleId><ArticleId IdType="pubmed">34905391</ArticleId></ArticleIdList></Reference><Reference><Citation>Depondt C, Donatello S, Rai M, Wang FC, Manto M, Simonis N, et al.. MME mutation in dominant spinocerebellar ataxia with neuropathy (SCA43). Neurol Genet. 2016; 2(5):e94. doi: 10.1212/NXG.0000000000000094</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000094</ArticleId><ArticleId IdType="pmc">PMC4991603</ArticleId><ArticleId IdType="pubmed">27583304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020; 20(2):74&#x2013;88. doi: 10.1038/s41568-019-0216-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-019-0216-7</ArticleId><ArticleId IdType="pmc">PMC7314312</ArticleId><ArticleId IdType="pubmed">31686003</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al.. Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021; 6(1):425. doi: 10.1038/s41392-021-00828-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00828-5</ArticleId><ArticleId IdType="pmc">PMC8677728</ArticleId><ArticleId IdType="pubmed">34916492</ArticleId></ArticleIdList></Reference><Reference><Citation>Tewari D, Patni P, Bishayee A, Sah AN, Bishayee A. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy. Semin Cancer Biol. 2022; 80:1&#x2013;17. doi: 10.1016/j.semcancer.2019.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2019.12.008</ArticleId><ArticleId IdType="pubmed">31866476</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi M, Perna E, Tronnolone S, Colecchia D, Chiariello M. Activated kinase screening identifies the IKBKE oncogene as a positive regulator of autophagy. Autophagy. 2019; 15(2):312&#x2013;326. doi: 10.1080/15548627.2018.1517855</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1517855</ArticleId><ArticleId IdType="pmc">PMC6333447</ArticleId><ArticleId IdType="pubmed">30289335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Xin Z, Hu W, Jiang S, Yang Z, Yan X, et al.. Forkhead box O proteins: Crucial regulators of cancer EMT. Semin Cancer Biol. 2018; 50:21&#x2013;31. doi: 10.1016/j.semcancer.2018.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2018.02.004</ArticleId><ArticleId IdType="pubmed">29427645</ArticleId></ArticleIdList></Reference><Reference><Citation>Miricescu D, Totan A, Stanescu S II, Badoiu SC, Stefani C, Greabu M. PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. Int J Mol Sci. 2020; 22(1):173. doi: 10.3390/ijms22010173</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010173</ArticleId><ArticleId IdType="pmc">PMC7796017</ArticleId><ArticleId IdType="pubmed">33375317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta D, Deb M, Kar S, Pradhan N, Parbin S, Kirtana R, et al.. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention. Semin Cancer Biol. 2021; 72:46&#x2013;64. doi: 10.1016/j.semcancer.2020.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2020.05.017</ArticleId><ArticleId IdType="pubmed">32497683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke J, Zhang BH, Li YY, Zhong M, Ma W, Xue H, et al.. MiR-1-3p suppresses cell proliferation and invasion and targets STC2 in gastric cancer. Eur Rev Med Pharmacol Sci. 2019; 23(20):8870&#x2013;8877. doi: 10.26355/eurrev_201910_19282</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_201910_19282</ArticleId><ArticleId IdType="pubmed">31696489</ArticleId></ArticleIdList></Reference><Reference><Citation>Guil S, Esteller M. RNA-RNA interactions in gene regulation: the coding and noncoding players. Trends Biochem Sci. 2015; 40(5):248&#x2013;256. doi: 10.1016/j.tibs.2015.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.03.001</ArticleId><ArticleId IdType="pubmed">25818326</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhao X, Liu Q, Liu Y. Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis. Ann Med. 2021; 53(1):1019&#x2013;1031. doi: 10.1080/07853890.2021.1914343</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2021.1914343</ArticleId><ArticleId IdType="pmc">PMC8253219</ArticleId><ArticleId IdType="pubmed">34187256</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Kees T, Almeida AS, Liu B, He XY, Ng D, et al.. Activating a collaborative innate-adaptive immune response to control metastasis. Cancer Cell. 2021; 39(10):1361&#x2013;1374.e9. doi: 10.1016/j.ccell.2021.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2021.08.005</ArticleId><ArticleId IdType="pmc">PMC8981964</ArticleId><ArticleId IdType="pubmed">34478639</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristinziano L, Modestino L, Antonelli A, Marone G, Simon HU, Varricchi G, et al.. Neutrophil extracellular traps in cancer. Semin Cancer Biol. 2022; 79:91&#x2013;104. doi: 10.1016/j.semcancer.2021.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2021.07.011</ArticleId><ArticleId IdType="pubmed">34280576</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>